Table 1 Correlation between PAFAH1B3 expression and the clinicopathological features of PDAC patients.
From: PAFAH1B3 is a KLF9 target gene that promotes proliferation and metastasis in pancreatic cancer
Characteristics | Total (85) | PAFAH1B3 | P value | |
|---|---|---|---|---|
Low expression group (35) | High expression group (50) | |||
Gender | ||||
Male | 49 | 22 | 27 | 0.416 |
Female | 36 | 13 | 23 | |
Age | ||||
< 60 | 32 | 13 | 19 | 0.936 |
≥ 60 | 53 | 22 | 31 | |
Tumor size (cm) | ||||
< 3.5 | 26 | 16 | 10 | 0.011* |
≥ 3.5 | 59 | 19 | 40 | |
Lymph node metastasis | ||||
Yes | 50 | 13 | 37 | 0.001** |
No | 35 | 22 | 13 | |
Tumor location | ||||
Head | 55 | 23 | 32 | 0.871 |
Body and tail | 30 | 12 | 18 | |
TNM stage | ||||
I/II | 36 | 26 | 10 | 0.000*** |
III | 49 | 9 | 40 | |
Differentiation | ||||
High | 12 | 5 | 7 | 0.987 |
Moderate | 43 | 18 | 25 | |
Low | 30 | 12 | 18 | |
